Zydus Pharmaceuticals Inc clomiPramine Hydrochloride, Capsules, USP, 25 mg recall: cGMP deviations: an observed Out of Specification of Nitrosamine Drug
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
The hazard: Harmful chemical exposure
A chemical contaminant is behind this recall. The official notice names the substance, and that name is what a clinician or Poison Control will want to hear.
What the notice says: cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
Why it matters: A chemical that should not be present at this level was found in the product. Depending on the substance, the concern may be a burn or irritation on contact, or a long-term risk from repeated exposure.
Symptoms and when to call a doctor
For a splash or spill, rinse the skin or eyes with running water for 15 to 20 minutes and remove contaminated clothing. If the product was swallowed, or if there is any trouble breathing, call Poison Control on 1-800-222-1222, which operates free and around the clock — or 911 if the person is collapsing, struggling to breathe or unconscious. Take the container or a photo of the label with you to any appointment.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0152-2026
- Published
- November 12, 2025
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Zydus Pharmaceuticals Inc
- Product type
- Prescription & OTC drugs
- Units affected
- N/A
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- a) Lot # E408871, Exp Date: 10/2026; Lot # E405282, Exp Date: 06/2026; Lot # E400386, Exp Date: 12/2025 b) Lot # E408872, Exp Date: 10/2026; Lot # E405280, Exp Date: 06/2026 c) Lot # E408873, Exp Date: 10/2026; Lot # E405281, Exp Date: 06/2026; Lot # E400387, Exp Date: 12/2025
Products covered by this recall
clomiPRAMINE Hydrochloride, Capsules, USP, 25 mg, packaged in a) 30-count bottles (NDC 16714-849-01), b) 90-count bottles (NDC 16714-849-02), c) 100-count bottles (NDC 16714-849-03), Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India
Check your product
The notice names 22 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- E408871
- E405282
- E400386
- E408872
- E405280
- E408873
- E405281
- E400387
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 10
- 2026
- 06
- 12
- 2025 b
- 2026 c
- 2025 — N
NDC number
On the carton and again on the bottle or blister label.
- 16714-849-01
- 16714-849-02
- 16714-849-03
Package size
Match the net weight or the piece count on the front of the pack.
- 25 mg
- 30 count
- 90 count
- 100 count
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Chemical
Zydus Pharmaceuticals Inc — A chemical contaminant is behind this recall. The official notice names the substance, and that name is what a clinician or Poison Control will want to hear.
- Stop using the product and keep it away from children and pets.
- Do not pour it down a drain or into a bin without checking local hazardous-waste rules, and never mix it with another cleaner.
- Ventilate the room if the product was sprayed or applied there.
- Keep the container — the lot code on it is what a refund claim and any medical follow-up both depend on.
Claiming your refund, repair or replacement
The recalling company decides the remedy and funds it. You should never pay for a recall repair or for return shipping.
- Use the company contact on this page first. Most firms run a dedicated recall page with a claim form that is far quicker than their main support line.
- If the company stops responding, escalate to the CPSC. Firms under a recall order have reporting duties to the agency.
- Have the model number, the date code and your photos ready. Many companies issue store credit by default — ask for cash or a card reversal if you would rather have it.
- No receipt? Say so. Recall refunds are routinely paid without proof of purchase, because the hazard is what triggers the obligation.
Company contact: Zydus Pharmaceuticals (USA) Inc — 73 Route 31 N, Pennington, NJ, 08534-3601
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Zydus Pharmaceuticals Inc prescription & otc drugs recalled?
cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit. cGMP deviations: an observed Out of Specification of Nitrosamine Drug Substance-Related Impurities (NDSRIs), N-Nitroso Desmethyl-Clomipramine, above the FDA acceptable intake limit.
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code E408871, E405282, E400386; best-by date 10 or 2026. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the product and keep it away from children and pets.
Can I get my money back?
Use the company contact on this page first. Most firms run a dedicated recall page with a claim form that is far quicker than their main support line.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 2 months ago
Zydus Pharmaceuticals Inc Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle recall: CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron
CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.
-
Class II · 5 months ago
Zydus Pharmaceuticals Inc Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle recall: CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
-
Class II · 5 months ago
Zydus Pharmaceuticals Inc Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle recall: CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above
CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit
-
Class II · 7 months ago
Zydus Pharmaceuticals Inc Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle recall: Failed Tablet/Capsule specifications: Red dots inside capsule and melted
Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
-
Class II · 9 months ago
Zydus Pharmaceuticals Inc Icosapent Ethyl capsules, 1 gram, 120-count bottles recall: Subpotent Drug: Due to oxidation caused by leakage of the contents
Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
-
Class III · 10 months ago
Zydus Pharmaceuticals Inc traZodone Hydrochloride Tablets, USP, 100mg, 1,000 Tablets recall: Failed Tablet/Capsule Specifications: Product complaint received that some
Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.